Marilyn C. Pike
- Molecular Biology top 10%
- Immunology top 5%
- Rheumatology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Oncology top 5%
- Co-authors
- Ralph SnydermanMichael SimonsRoger J. LahamJames E. UdelsonM.J. WhitehouseNicolas A.F. ChronosNeal S. KleimanHarold L. Dauerman
- Topics
- Immune cells in cancer (9 papers)Systemic Lupus Erythematosus Research (5 papers)Cytokine Signaling Pathways and Interactions (5 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Marilyn C. Pike
36 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 1.1k
- Immunology 890
- Rheumatology 592
- Radiology, Nuclear Medicine and Imaging 525
- Oncology 514
Countries citing papers authored by Marilyn C. Pike
This map shows the geographic impact of Marilyn C. Pike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn C. Pike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn C. Pike more than expected).
Fields of papers citing papers by Marilyn C. Pike
This network shows the impact of papers produced by Marilyn C. Pike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn C. Pike. The network helps show where Marilyn C. Pike may publish in the future.
Co-authorship network of co-authors of Marilyn C. Pike
This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn C. Pike. A scholar is included among the top collaborators of Marilyn C. Pike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn C. Pike. Marilyn C. Pike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase | 139 |
| 4 | 169 | |
| 5 | 250 | |
| 6 | 11 | |
| 7 | 118 | |
| 8 | Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2breakdown → | 512 |
| 9 | 40 | |
| 10 | 170 | |
| 11 | 39 | |
| 12 | 15 | |
| 13 | Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. | 81 |
| 14 | 20 | |
| 15 | 17 | |
| 16 | 1 | |
| 17 | 38 | |
| 18 | 45 | |
| 19 | 56 | |
| 20 | 117 |
About Marilyn C. Pike
Marilyn C. Pike is a scholar working on Immunology, Immunology and Allergy and Rheumatology, having authored 36 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immune cells in cancer (9 papers), Systemic Lupus Erythematosus Research (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). The work is most often cited by research in Immunology (890 citations), Rheumatology (592 citations) and Radiology, Nuclear Medicine and Imaging (525 citations). Marilyn C. Pike has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Ralph Snyderman, Michael Simons, Roger J. Laham, James E. Udelson, M.J. Whitehouse, Nicolas A.F. Chronos, Neal S. Kleiman, Harold L. Dauerman, Timothy D. Henry and Brian H. Annex. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.